In a recent study posted to the medRxiv* preprint server, researchers investigated whether the second booster dose of monovalent coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA) ...
Credit: Getty Images. This randomized, placebo-controlled, double-blind phase 3 trial aimed to evaluate the safety, efficacy, and immunogenicity of a combined protein-based vaccination strategy. This ...
A recent study posted to the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) assessed the efficacy of severe acute respiratory syndrome coronavirus 2 ...
SARS-CoV-2 vaccination is thought to protect nursing home residents, as it does the general population, but data are sparse because clinical trials were not conducted in nursing homes. Investigators ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to be an international public health emergency due to rapid human-to-human transmission, emergence of new variants, high ...
In what may be the first case of North American tech operations being affected by the mysterious SARS virus, Hewlett-Packard has sent about 200 workers home from a Toronto-area office amid concerns ...
Modern Forms has reported that the Ultra Smart Fan, with a patented system that combines an Ultraviolet-C (UV-C) radiating LED module with an air-circulating fan to decrease airborne pathogens in ...
"I want to go home, because this is my first year studying abroad. . . . But I care about my health, too." Severe acute respiratory syndrome, or SARS, is creating concerns on college campuses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback